PTK2B/Pyk2 overexpression improves a mouse model of Alzheimer's disease
暂无分享,去创建一个
Jean-Antoine Girault | J. Girault | V. Deramecourt | S. Arold | J. Hugon | C. Cifuentes-Díaz | A. Giralt | Jacques Hugon | Vincent Deramecourt | S. Ginés | Stefan T Arold | M. Tible | Silvia Ginés | Marion Tible | Benoit de Pins | L. López-Molina | Amel Thamila Farah | Albert Giralt | Benoit de Pins | Carmen Cifuentes-Díaz | Laura López-Molina | A. Farah
[1] W. Thies,et al. 2013 Alzheimer's disease facts and figures , 2013, Alzheimer's & Dementia.
[2] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.
[3] S. Strittmatter,et al. Disease-modifying benefit of Fyn blockade persists after washout in mouse Alzheimer's model , 2018, Neuropharmacology.
[4] J. Hell,et al. Postsynaptic Clustering and Activation of Pyk2 by PSD-95 , 2010, The Journal of Neuroscience.
[5] A. Scaloni,et al. Platelet-derived Growth Factor Induces the β-γ-Secretase-mediated Cleavage of Alzheimer's Amyloid Precursor Protein through a Src-Rac-dependent Pathway* , 2003, The Journal of Biological Chemistry.
[6] B. Strooper,et al. The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes , 2012, Nature Neuroscience.
[7] C. Bouras,et al. The PKR Activator PACT Is Induced by Aβ: Involvement in Alzheimer's Disease , 2012, Brain pathology.
[8] L. Mucke,et al. Neurotoxicity of amyloid β-protein: synaptic and network dysfunction. , 2012, Cold Spring Harbor perspectives in medicine.
[9] C. Lipinski,et al. Targeting Pyk2 for therapeutic intervention , 2010, Expert opinion on therapeutic targets.
[10] S. Strittmatter,et al. Oligomers of Amyloid β Prevent Physiological Activation of the Cellular Prion Protein-Metabotropic Glutamate Receptor 5 Complex by Glutamate in Alzheimer Disease* , 2016, The Journal of Biological Chemistry.
[11] Jerry R. Thomas,et al. Multisite tyrosine phosphorylation of the N‐terminus of Mint1/X11α by Src kinase regulates the trafficking of amyloid precursor protein , 2016, Journal of neurochemistry.
[12] M. Sheng,et al. Proline-Rich Tyrosine Kinase 2 Regulates Hippocampal Long-Term Depression , 2010, The Journal of Neuroscience.
[13] J. Becker,et al. Genetic determinants of disease progression in Alzheimer's disease. , 2014, Journal of Alzheimer's disease : JAD.
[14] E. Mandelkow,et al. Biochemistry and cell biology of tau protein in neurofibrillary degeneration. , 2012, Cold Spring Harbor perspectives in medicine.
[15] D. Alkon,et al. PKC ε Activation Prevents Synaptic Loss, Aβ Elevation, and Cognitive Deficits in Alzheimer's Disease Transgenic Mice , 2011, The Journal of Neuroscience.
[16] Margaret A. Pericak-Vance,et al. Genome-Wide Association Meta-analysis of Neuropathologic Features of Alzheimer's Disease and Related Dementias , 2014, PLoS genetics.
[17] S. Lipton,et al. Oligomeric Aβ-induced synaptic dysfunction in Alzheimer’s disease , 2014, Molecular Neurodegeneration.
[18] M. Pallàs,et al. Epigenetic mechanisms underlying cognitive impairment and Alzheimer disease hallmarks in 5XFAD mice , 2016, Aging.
[19] H. Soininen,et al. Functional screening of Alzheimer risk loci identifies PTK2B as an in vivo modulator and early marker of Tau pathology , 2016, Molecular Psychiatry.
[20] H. Vinters,et al. Emerging concepts in Alzheimer's disease. , 2015, Annual review of pathology.
[21] Yu Tian Wang,et al. A balance between excitatory and inhibitory synapses is controlled by PSD-95 and neuroligin. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[22] J. Girault,et al. Depolarization Activates ERK and Proline-rich Tyrosine Kinase 2 (PYK2) Independently in Different Cellular Compartments in Hippocampal Slices* , 2005, Journal of Biological Chemistry.
[23] J. Hell,et al. Striatal-enriched Protein-tyrosine Phosphatase (STEP) Regulates Pyk2 Kinase Activity* , 2012, The Journal of Biological Chemistry.
[24] George Perry,et al. Reexamining Alzheimer's disease: evidence for a protective role for amyloid-beta protein precursor and amyloid-beta. , 2009, Journal of Alzheimer's disease : JAD.
[25] J. Girault,et al. FAK+ and PYK2/CAKβ, two related tyrosine kinases highly expressed in the central nervous system: similarities and differences in the expression pattern , 1999, The European journal of neuroscience.
[26] M. Giordano,et al. Beta‐amyloid protein (25–35) disrupts hippocampal network activity: Role of Fyn‐kinase , 2009, Hippocampus.
[27] Mary Miu Yee Waye,et al. Polygenic Analysis of Late-Onset Alzheimer’s Disease from Mainland China , 2015, PloS one.
[28] J. Aten,et al. Measurement of co‐localization of objects in dual‐colour confocal images , 1993, Journal of microscopy.
[29] J. Pozueta,et al. Synaptic changes in Alzheimer’s disease and its models , 2013, Neuroscience.
[30] J. Girault,et al. Pyk2 modulates hippocampal excitatory synapses and contributes to cognitive deficits in a Huntington's disease model , 2017, Nature Communications.
[31] Reduced IGF-1 signaling delays age-associated proteotoxicity in mice. , 2009, Cell.
[32] Kristine Yaffe,et al. Gene-based aggregate SNP associations between candidate AD genes and cognitive decline , 2016, AGE.
[33] T. Morgan,et al. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[34] S. Strittmatter,et al. Fyn inhibition rescues established memory and synapse loss in Alzheimer mice , 2015, Annals of neurology.
[35] Bernardo L Sabatini,et al. Synapses and Alzheimer's disease. , 2012, Cold Spring Harbor perspectives in biology.
[36] M. Tansey,et al. Peripheral administration of the soluble TNF inhibitor XPro1595 modifies brain immune cell profiles, decreases beta-amyloid plaque load, and rescues impaired long-term potentiation in 5xFAD mice , 2017, Neurobiology of Disease.
[37] J. Roder,et al. CAKβ/Pyk2 Kinase Is a Signaling Link for Induction of Long-Term Potentiation in CA1 Hippocampus , 2001, Neuron.
[38] S. Lev,et al. A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation , 1996, Nature.
[39] A. Hill,et al. A Truncated Fragment of Src Protein Kinase Generated by Calpain-mediated Cleavage Is a Mediator of Neuronal Death in Excitotoxicity* , 2013, The Journal of Biological Chemistry.
[40] Jürgen Götz,et al. Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models , 2010, Cell.
[41] John W. Gilbert,et al. Cellular Prion Protein Mediates Impairment of Synaptic Plasticity by Amyloid-β Oligomers , 2009, Nature.
[42] A. Maelicke,et al. Galantamine Slows Down Plaque Formation and Behavioral Decline in the 5XFAD Mouse Model of Alzheimer’s Disease , 2014, PloS one.
[43] M. Ohno,et al. Intraneuronal β-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation , 2006, The Journal of Neuroscience.
[44] Nick C Fox,et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease , 2013, Nature Genetics.
[45] J. Girault,et al. Pyk2 is essential for astrocytes mobility following brain lesion , 2016, Glia.
[46] Shin-Young Park,et al. RAFTK/Pyk2 Activation Is Mediated by Trans-acting Autophosphorylation in a Src-independent Manner* , 2004, Journal of Biological Chemistry.
[47] O. Garaschuk,et al. Neuroinflammation in Alzheimer's disease , 2015, The Lancet Neurology.
[48] T. Sacktor,et al. Postsynaptic degeneration as revealed by PSD-95 reduction occurs after advanced Aβ and tau pathology in transgenic mouse models of Alzheimer’s disease , 2011, Acta Neuropathologica.
[49] J. Girault,et al. How to awaken your nanomachines: Site-specific activation of focal adhesion kinases through ligand interactions. , 2015, Progress in biophysics and molecular biology.
[50] J. Girault,et al. Differential Regulation of Proline-rich Tyrosine Kinase 2/Cell Adhesion Kinase β (PYK2/CAKβ) and pp125FAK by Glutamate and Depolarization in Rat Hippocampus* , 1996, The Journal of Biological Chemistry.
[51] J. Girault,et al. FAK and PYK2/CAKβ in the nervous system: a link between neuronal activity, plasticity and survival? , 1999, Trends in Neurosciences.
[52] P. Greengard,et al. Inhibitor of the Tyrosine Phosphatase STEP Reverses Cognitive Deficits in a Mouse Model of Alzheimer's Disease , 2014, PLoS biology.
[53] Sascha Weggen,et al. Alzheimer therapy with an antibody against N-terminal Abeta 4-X and pyroglutamate Abeta 3-X , 2015, Scientific Reports.
[54] Robert A. H. White,et al. Identification and Characterization of a Novel Related Adhesion Focal Tyrosine Kinase (RAFTK) from Megakaryocytes and Brain (*) , 1995, The Journal of Biological Chemistry.
[55] Terukatsu Sasaki,et al. Cloning and Characterization of Cell Adhesion Kinase β, a Novel Protein-tyrosine Kinase of the Focal Adhesion Kinase Subfamily (*) , 1995, The Journal of Biological Chemistry.
[56] E. Peles,et al. Protein tyrosine kinase PYK2 involved in Ca2+-induced regulation of ion channel and MAP kinase functions , 1995, Nature.
[57] Y. Matsuoka,et al. Fyn knock-down increases Aβ, decreases phospho-tau, and worsens spatial learning in 3×Tg-AD mice , 2012, Neurobiology of Aging.
[58] B. Jenkins,et al. Combination therapy in a transgenic model of Alzheimer's disease , 2013, Experimental Neurology.
[59] K. Reymann,et al. Behavioral and EEG changes in male 5xFAD mice , 2014, Physiology & Behavior.
[60] J. Götz,et al. Somatodendritic accumulation of Tau in Alzheimer's disease is promoted by Fyn‐mediated local protein translation , 2017, The EMBO journal.